12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Acura, Pfizer deal

Acura said Pfizer completed the return of three pain products developed using Acura's Aversion abuse-deterrent technology...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >